Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy
Eye (Lond)
.
2017 Jan;31(1):163-164.
doi: 10.1038/eye.2016.215.
Epub 2016 Oct 7.
Authors
F Ricci
1
,
M Parravano
2
,
F Regine
1
,
M Sciamanna
2
,
M Tedeschi
2
,
F Missiroli
1
,
M Varano
2
Affiliations
1
Department of Ophthalmology, University of Rome Tor Vergata, Rome, Italy.
2
Department of Ophthalmology, Fondazione G.B.Bietti-IRCCS, Rome, Italy.
PMID:
27716748
PMCID:
PMC5233939
DOI:
10.1038/eye.2016.215
No abstract available
Publication types
Kommentar
MeSH terms
Humans
Receptors, Vascular Endothelial Growth Factor*
Recombinant Fusion Proteins
Wet Macular Degeneration*
Substances
Recombinant Fusion Proteins
aflibercept
Receptors, Vascular Endothelial Growth Factor